Global Transplant Diagnostics Market Analysis, Trends & Industry Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Global Transplant Diagnostics Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Transplant Diagnostics Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising number of transplant procedures, increased incidence of chronic diseases and increasing public-private funding for target research activities.

Based on Technology, market is divided into non-molecular assays and molecular assays. Non-Molecular Assays is further divided into Mixed Lymphocyte Culture (MLC) Assays and Serological Assays. Molecular Assays is sub divided into sequencing-based molecular assays and PCR-based molecular assays.

By Transplant Type, market is classified into Stem Cell Transplantation, Soft Tissue Transplantation and Solid Organ Transplantation. Solid Organ Transplantation is further segmented into pancreas transplantation, kidney transplantation, heart transplantation, lung transplantation, liver transplantation and other organ transplantations.

By Application, market is categorized into Research Applications and Diagnostic Applications. Diagnostic Applications is further classified into post-transplantation diagnostics and pre-transplantation diagnostics.

Depending upon End User, market is categorized into hospitals & transplant centers, independent reference laboratories, commercial service providers and research laboratories & academic institutes.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 to 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

Companies Mentioned

  • Biofortuna
  • Illumina
  • Merck KGaA
  • Omixon
  • Thermo Fisher Scientific
  • F. Hoffman-La Roche Limited
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Caredx
  • Immucor
  • Luminex
  • Qiagen
  • Hologic
  • Gendx
  • Abbott

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Transplant Diagnostics Market, By Technology

5 Transplant Diagnostics Market, By Transplant Type

6 Transplant Diagnostics Market, By Product and Services

7 Transplant Diagnostics Market, By Application

8 Transplant Diagnostics Market, By End User

9 Transplant Diagnostics Market, By Geography

10 Key Player Activities

11 Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/7kpfj2/global_transplant?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics